Please assess the completion status of the following clinical trial:

Trial Title: Benefits of ICD for the Primary Prevention in Patients With Valvular Cardiomyopathy

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients who meet one of the following criteria:~  * Patients who have undergone surgery for aortic valve or mitral valve disease for more than 12 months~ * Patients with severe aortic valve or mitral valve disease~* Patients with left ventricular ejection fraction ≤ 35% by echocardiography or other imaging methods~* US, European practice guidelines class I indication for ICD implantation~* Patients without evidence of ischemic heart disease (who meet one of the following criteria):~  * Stress test negative~ * Significant stenosis was not observed in coronary artery images:~epicardial coronary stenosis \<70%, left main stenosis \<50%~* History of heart failure symptoms~* Patients who have received medication for more than 3 months according to the heart failure treatment guideline recommendation~Exclusion Criteria:~* Patients with left ventricular dysfunction without valvular heart disease~* Patients who require cardiac pacing therapy due to bradycardia~* Heart transplant scheduled~* Life expectancy is less than one year

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Valvular heart disease (Type: None): Patients with left ventricular dysfunction due to valvular heart disease who received ICD implantation for primary prevention of sudden cardiac death.

Based on this trial design, predict the completion outcome and termination type (if applicable).